Cargando…
Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib
BACKGROUND: Extraskeletal myxoid chondrosarcoma (EMCS) is a rare soft tissue sarcoma of uncertain differentiation, characterized in most cases by a translocation that results in the fusion protein EWSR1-CHN (the latter even called NR4A3 or TEC). EMCS is marked by >40% incidence of metastases in s...
Autores principales: | Stacchiotti, Silvia, Dagrada, Gian Paolo, Morosi, Carlo, Negri, Tiziana, Romanini, Antonella, Pilotti, Silvana, Gronchi, Alessandro, Casali, Paolo G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534218/ https://www.ncbi.nlm.nih.gov/pubmed/23058004 http://dx.doi.org/10.1186/2045-3329-2-22 |
Ejemplares similares
-
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study
por: Stacchiotti, Silvia, et al.
Publicado: (2013) -
Identification of an Actionable Mutation of KIT in a Case of Extraskeletal Myxoid Chondrosarcoma
por: Urbini, Milena, et al.
Publicado: (2018) -
Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management
por: Stacchiotti, Silvia, et al.
Publicado: (2020) -
NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas
por: Brenca, Monica, et al.
Publicado: (2019) -
Extraskeletal Myxoid Chondrosarcoma of the Orbit
por: Al-Osaily, Abdullah M., et al.
Publicado: (2016)